- Investing Ideas
- /
- Hong Kong Healthcare Undervalued Stocks Based On Cash Flows
Hong Kong Healthcare Undervalued Stocks Based On Cash Flows
Results
5
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
5 companies
Peijia Medical
Market Cap: HK$5.8b
Engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People’s Republic of China.
9996
HK$8.68
7D
8.4%
1Y
284.1%
Shanghai Conant Optical
Market Cap: HK$21.0b
Manufactures and sells resin spectacle lenses in Mainland China, the Americas, Asia, Europe, Oceania, and Africa.
2276
HK$43.70
7D
1.9%
1Y
282.0%
OrbusNeich Medical Group Holdings
Market Cap: HK$4.5b
An investment holding company, engages in the manufacturing, trading, sales, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People’s Republic of China, and the United States.
6929
HK$5.48
7D
24.8%
1Y
69.1%
MicroPort CardioFlow Medtech
Market Cap: HK$3.3b
A medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally.
2160
HK$1.35
7D
6.3%
1Y
90.1%
Beijing Chunlizhengda Medical Instruments
Market Cap: HK$8.7b
Beijing Chunlizhengda Medical Instruments Co., Ltd.
1858
HK$16.70
7D
10.7%
1Y
110.1%